- Home
- KMDA vs DXYZ Comparison
KMDA vs DXYZ Comparison
Compare KMDA & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- DXYZ
- Stock Information
- Founded
- KMDA 1990
- DXYZ N/A
- Country
- KMDA Israel
- DXYZ
- Employees
- KMDA N/A
- DXYZ N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- DXYZ
- Sector
- KMDA Health Care
- DXYZ
- Exchange
- KMDA Nasdaq
- DXYZ Nasdaq
- Market Cap
- KMDA 399.7M
- DXYZ 413.3M
- IPO Year
- KMDA N/A
- DXYZ 2024
- Fundamental
- Price
- KMDA $7.74
- DXYZ $37.12
- Analyst Decision
- KMDA Strong Buy
- DXYZ
- Analyst Count
- KMDA 3
- DXYZ 0
- Target Price
- KMDA $14.67
- DXYZ N/A
- AVG Volume (30 Days)
- KMDA 83.7K
- DXYZ N/A
- Earning Date
- KMDA 08-13-2025
- DXYZ N/A
- Dividend Yield
- KMDA 2.56%
- DXYZ N/A
- EPS Growth
- KMDA 31.21
- DXYZ N/A
- EPS
- KMDA 0.28
- DXYZ N/A
- Revenue
- KMDA $167,235,000.00
- DXYZ N/A
- Revenue This Year
- KMDA $14.51
- DXYZ N/A
- Revenue Next Year
- KMDA $9.31
- DXYZ N/A
- P/E Ratio
- KMDA $27.53
- DXYZ N/A
- Revenue Growth
- KMDA 11.83
- DXYZ N/A
- 52 Week Low
- KMDA $4.93
- DXYZ N/A
- 52 Week High
- KMDA $9.16
- DXYZ N/A
- Technical
- Relative Strength Index (RSI)
- KMDA 66.78
- DXYZ N/A
- Support Level
- KMDA $7.68
- DXYZ N/A
- Resistance Level
- KMDA $7.86
- DXYZ N/A
- Average True Range (ATR)
- KMDA 0.21
- DXYZ 0.00
- MACD
- KMDA 0.05
- DXYZ 0.00
- Stochastic Oscillator
- KMDA 67.61
- DXYZ 0.00
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About DXYZ Destiny Tech100 Inc. Common Stock
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.